Logo image of MKL

MARKEL GROUP INC (MKL) Stock Fundamental Analysis

USA - NYSE:MKL - US5705351048 - Common Stock

1940.2 USD
+19.45 (+1.01%)
Last: 10/3/2025, 1:02:50 PM
Fundamental Rating

4

MKL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. There are concerns on the financial health of MKL while its profitability can be described as average. MKL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MKL had positive earnings in the past year.
In the past year MKL had a positive cash flow from operations.
Of the past 5 years MKL 4 years were profitable.
Each year in the past 5 years MKL had a positive operating cash flow.
MKL Yearly Net Income VS EBIT VS OCF VS FCFMKL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

With a decent Return On Assets value of 3.22%, MKL is doing good in the industry, outperforming 68.49% of the companies in the same industry.
MKL has a Return On Equity (12.42%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.22%
ROE 12.42%
ROIC N/A
ROA(3y)2.38%
ROA(5y)2.8%
ROE(3y)8.69%
ROE(5y)9.72%
ROIC(3y)N/A
ROIC(5y)N/A
MKL Yearly ROA, ROE, ROICMKL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

MKL's Profit Margin of 13.07% is fine compared to the rest of the industry. MKL outperforms 75.34% of its industry peers.
In the last couple of years the Profit Margin of MKL has declined.
MKL has a better Operating Margin (20.40%) than 80.14% of its industry peers.
In the last couple of years the Operating Margin of MKL has declined.
Industry RankSector Rank
OM 20.4%
PM (TTM) 13.07%
GM N/A
OM growth 3Y-3.99%
OM growth 5Y-3%
PM growth 3Y-6.22%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MKL Yearly Profit, Operating, Gross MarginsMKL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

3

2. Health

2.1 Basic Checks

MKL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MKL has been reduced compared to 1 year ago.
MKL has less shares outstanding than it did 5 years ago.
MKL has a worse debt/assets ratio than last year.
MKL Yearly Shares OutstandingMKL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MKL Yearly Total Debt VS Total AssetsMKL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

MKL has a debt to FCF ratio of 2.13. This is a good value and a sign of high solvency as MKL would need 2.13 years to pay back of all of its debts.
The Debt to FCF ratio of MKL (2.13) is comparable to the rest of the industry.
MKL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.25, MKL is doing good in the industry, outperforming 63.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.13
Altman-Z N/A
ROIC/WACCN/A
WACC8.06%
MKL Yearly LT Debt VS Equity VS FCFMKL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MKL Yearly Current Assets VS Current LiabilitesMKL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.53% over the past year.
Measured over the past years, MKL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.39% on average per year.
MKL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.66%.
Measured over the past years, MKL shows a quite strong growth in Revenue. The Revenue has been growing by 11.78% on average per year.
EPS 1Y (TTM)9.53%
EPS 3Y4.51%
EPS 5Y13.39%
EPS Q2Q%-48.52%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y8.97%
Revenue growth 5Y11.78%
Sales Q2Q%20.56%

3.2 Future

MKL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.31% yearly.
MKL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.46% yearly.
EPS Next Y32.26%
EPS Next 2Y21.74%
EPS Next 3Y17.86%
EPS Next 5Y13.31%
Revenue Next Year-3.55%
Revenue Next 2Y-1.11%
Revenue Next 3Y1.35%
Revenue Next 5Y3.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MKL Yearly Revenue VS EstimatesMKL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
MKL Yearly EPS VS EstimatesMKL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 50 -50 100

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 31.08 indicates a quite expensive valuation of MKL.
MKL's Price/Earnings ratio is a bit more expensive when compared to the industry. MKL is more expensive than 78.77% of the companies in the same industry.
MKL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.93, MKL is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MKL indicates a slightly more expensive valuation: MKL is more expensive than 64.38% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MKL to the average of the S&P500 Index (23.29), we can say MKL is valued slightly cheaper.
Industry RankSector Rank
PE 31.08
Fwd PE 17.93
MKL Price Earnings VS Forward Price EarningsMKL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

66.44% of the companies in the same industry are more expensive than MKL, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as MKL.
Industry RankSector Rank
P/FCF 11.98
EV/EBITDA 6.74
MKL Per share dataMKL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800 1K

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MKL's earnings are expected to grow with 17.86% in the coming years.
PEG (NY)0.96
PEG (5Y)2.32
EPS Next 2Y21.74%
EPS Next 3Y17.86%

More info and screens

0

5. Dividend

5.1 Amount

MKL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARKEL GROUP INC

NYSE:MKL (10/3/2025, 1:02:50 PM)

1940.2

+19.45 (+1.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners82.81%
Inst Owner Change-2.44%
Ins Owners1.41%
Ins Owner Change0.35%
Market Cap24.54B
Analysts51.43
Price Target2018.58 (4.04%)
Short Float %1.63%
Short Ratio4.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.78
Dividend Growth(5Y)N/A
DP1.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.29%
Min EPS beat(2)-45.1%
Max EPS beat(2)36.52%
EPS beat(4)2
Avg EPS beat(4)-18.28%
Min EPS beat(4)-119.59%
Max EPS beat(4)55.06%
EPS beat(8)5
Avg EPS beat(8)-22.64%
EPS beat(12)8
Avg EPS beat(12)-9.57%
EPS beat(16)12
Avg EPS beat(16)4.5%
Revenue beat(2)1
Avg Revenue beat(2)4.72%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)16.08%
Revenue beat(4)1
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)16.08%
Revenue beat(8)3
Avg Revenue beat(8)4.69%
Revenue beat(12)6
Avg Revenue beat(12)5.81%
Revenue beat(16)7
Avg Revenue beat(16)3.3%
PT rev (1m)0%
PT rev (3m)1.93%
EPS NQ rev (1m)0.38%
EPS NQ rev (3m)-1.35%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)-2.84%
Revenue NQ rev (1m)1.72%
Revenue NQ rev (3m)0.49%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)3.61%
Valuation
Industry RankSector Rank
PE 31.08
Fwd PE 17.93
P/S 1.49
P/FCF 11.98
P/OCF 10.83
P/B 1.42
P/tB 1.91
EV/EBITDA 6.74
EPS(TTM)62.42
EY3.22%
EPS(NY)108.23
Fwd EY5.58%
FCF(TTM)161.91
FCFY8.34%
OCF(TTM)179.08
OCFY9.23%
SpS1300.72
BVpS1369.02
TBVpS1017.74
PEG (NY)0.96
PEG (5Y)2.32
Profitability
Industry RankSector Rank
ROA 3.22%
ROE 12.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 20.4%
PM (TTM) 13.07%
GM N/A
FCFM 12.45%
ROA(3y)2.38%
ROA(5y)2.8%
ROE(3y)8.69%
ROE(5y)9.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.99%
OM growth 5Y-3%
PM growth 3Y-6.22%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.13
Debt/EBITDA 1.18
Cap/Depr 63.44%
Cap/Sales 1.32%
Interest Coverage 250
Cash Conversion 61.24%
Profit Quality 95.24%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.06%
ROIC/WACCN/A
Cap/Depr(3y)81.13%
Cap/Depr(5y)63.91%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.53%
EPS 3Y4.51%
EPS 5Y13.39%
EPS Q2Q%-48.52%
EPS Next Y32.26%
EPS Next 2Y21.74%
EPS Next 3Y17.86%
EPS Next 5Y13.31%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y8.97%
Revenue growth 5Y11.78%
Sales Q2Q%20.56%
Revenue Next Year-3.55%
Revenue Next 2Y-1.11%
Revenue Next 3Y1.35%
Revenue Next 5Y3.46%
EBIT growth 1Y13.76%
EBIT growth 3Y4.62%
EBIT growth 5Y8.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.41%
FCF growth 3Y3.19%
FCF growth 5Y15.24%
OCF growth 1Y-19.01%
OCF growth 3Y4.48%
OCF growth 5Y15.28%